Screener
Lexicon Pharmaceuticals LXRX Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Assets | As of June 30, 2026 / (unaudited) | As of December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 7) | ||
| Stockholders’ Equity: | ||
| Convertible preferred stock, $0.01 par value; 5,000,000 shares authorized2,712,582 and 2,304,147 shares issued at June 30, 2026 and December 31, 2025, respectively; none outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value; 900,000,000 shares authorized at June 30, 2026; 446,870,629 and 365,848,216 shares issued, respectively | 447 | 366 |
| Additional paid-in capital | 2,227,526 | 2,129,912 |
| Accumulated deficit | (2,050,401) | (2,017,583) |
| Accumulated other comprehensive (loss) income | (204) | 30 |
| Treasury stock, at cost, 1,933,747 and 2,381,939 shares, respectively | (2,843) | (5,187) |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's common stock, par value (in dollars per share)?
- Lexicon Pharmaceuticals (LXRX) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
- How has Lexicon Pharmaceuticals's common stock, par value (in dollars per share) changed year-over-year?
- Lexicon Pharmaceuticals's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Lexicon Pharmaceuticals's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
- What does common stock, par value (in dollars per share) mean?
- Common stock, par value (in dollars per share)
Ask your AI about Lexicon Pharmaceuticals's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude